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Thediversity ofthe antigenbindingportion oftheIgmoleculeis generatedthrough
the recombination ofmultiple discontinuous gene segments (1, 2). Theheavy chain
variable (V) region coding sequence is formed when one ofhundreds ofVN regions
combines with one of 15-20 D regions and one of 4J. regions to create a complete
VDJ segment (3, 4). Light chain recombination proceeds in a similar fashion be-
tween V,, andJL segments (5). These events occur in a well-defined order with DJ.
rearrangement precedingV.-to-DJ. recombination (6, 7), followed later by V,;to-
J,, recombination. The exact site of recombination between these segments is impre-
cise, thus creating further diversity at thejoints. Single nucleotides (N segments)
may be added at the limits of the D region in heavy chain rearrangements (8, 9).
These mechanisms, along with the association of different heavy and light chains,
result in an expected antibody repertoire of >1011 Ig molecules.
In recent yearsit has become apparent that rearranged VDJ segments are capable
of undergoing further somatic variation. A majormechanism of generating further
diversity is somatic point mutation within the V region coding sequence (1, 10).
This process appears to be focusedwithin and nearby the rearranged V region genes.
Somatic point mutation of these genes has been estimated to occur at a rate as high
as 10-s/bp/generation (11, 12). It occurs during the late primary and during the
generation ofthesecondary immune response (13). It mayalterboth antigen specificity
and affinity (14). In addition to somatic mutation, less frequently implicated molec-
ular events such as gene conversion or V region replacement may modify already
expressed Ig genes (15-18). These processes appear to occur during specific stages
of B cell differentiation and may be limited to certain B cell subsets (17).
The molecular basis of somatic diversification may be studied in greater detail
by examining B cell tumors. Tumors that represent discrete stages or lineages of
normal B cell development and have been adaptedto growth in vitro should be good
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candidates for such studies . Recently we have described surface Ig` idiotype-
negative (sIg+, Id- ) 1 tumor variants in the murine lymphoma 38013 (19) . This B
cell lymphoma bears surface IgK but secretes little of this molecule, and therefore,
is an excellent model for immunotherapy targeted against its Id . We generated a
panel of syngeneic antiidiotype mAbs and have examined their antitumor effects
(20, 21) . We found minor tumor subpopulations that failed to react with one or an-
other of the antiidiotype antibodies, Such variants could be selected either in vivo
(19) or in vitro . Previously we reported biochemical and serologic differences be-
tween tumor variants (19) . Antisera and mAbs were produced that distinguished
each individual variant Id protein . The Ig produced by the tumor variants differed
from one another in the migration of their K light chain proteins on SDS-PAGE .
We found that their K light chain gene rearrangements were also different from one
another and from the parental 38C13 lymphoma . Here we describe the molecular
basis of this heterogeneity.
Materials and Methods
Tumor Cell Lines .
￿
The 38013 murine B celllymphoma ofC3H origin, and mAbs directed
against its cell surface idiotypic determinants have been described in detail previously (20-23) .
Tumor cell lines were grown in RPMI 1640 medium (Irvine Scientific, Irvine, CA), sup-
plemented with 12% FCS, penicillin, streptomycin (Sigma Chemical Co., St . Louis, MO),
L-glutamine (Gibco Laboratories, Grand Island, NY), 10 mm Hepes (Gibco Laboratories),
and 5 x 10-5 M 2-ME in a humidified 37 °C, 5% C02 incubator. Id variants were selected
by methods outlined earlier (19) . Briefly, fourdifferent classes oftumor variants were isolated
on the basis of surface Ig expression and binding to two different anti-Id antibodies, SIC5
and S5A8 . Three ofthese variants were recovered from mice whose tumors regrew after therapy
in vivo with SIC5 . One of these variants, VI, retained surface Ig expression, but failed to
bind both anti-Id mAbs . Variant V2 lost surface Ig expression altogether. Another variant,
V3, was sIg', lost binding to antibody SIC5, but still bound antibody S5A8 . A fourth
variant, V4, was isolated after the 38013 tumor was exposed in vitro to S5A8 coupled to
recombinant A chain of ricin . This sIg' variant lost binding to antibody S5A8 but retained
binding to SIC5 . Binding in all these cases was assessed on whole cells by flow cytometry
and confirmed by ELISA on Ig proteins isolated from the variant tumor cells (see below) .
These characteristics are summarized in Table I .
To recover large amounts of protein and mRNA for cDNA synthesis, variant tumor cell
lines were fused to the nonsecreting mouse myeloma 8.653 as previously described (19, 23) .
Hybrids were selected with HAT medium . The absence of2-ME prevented the growth of
parental tumor cells . The resulting hybrids were screened for Ig production and were cloned
by limiting dilution . Protein was isolated by affinity chromatography and anti-Id binding
was examined by the ELISA method (19) . In each case the Id determinants expressed on
the tumor cell surface and by the isolated protein were identical .
Southern Analysis ofRearranged V, Genes.
￿
High molecular weight DNA was isolated from
the original 38013 lymphoma, the tumor variants VI-V4, their respective hybridomas, the
P3x63 8.653 myeloma fusion partner, and C3H liver. 10 gg ofDNA was digested with Barn
HI restriction endonuclease (New England Biolabs, Beverly, MA) and loaded on a 0.8% agarose
gel . Samples were transferred to an activated nylon filter (Genatran 45 ; Plasco Inc ., Woburn,
MA) according to the method of Southern (24) . Filters were baked under vacuum at 80°C
for 2 h . Prehybridization was carried out at 42°C for 6 h in 50% formamide, 3 x SSC, 5 x
Denhardt's solution, 1mM sodium pyrophosphate, and 100 ug/ml of denatured salmon sperm
DNA .
Hybridization was performed under identical conditions with the exception of the addi-
' Abbreviations used in this paper : Id, idiotype ; sIg, surface immunoglobulin .CARROLL ET AL .
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TABLE I
mAb Reactivity of Tumor Subclones
' Syngeneic antiidiotype mAbs raised against the 38C13 Ig protein .
tion of 8% Dextran sulphate and the radioactive probe . The filter was washed in 2 x SSC
0.1% SDS at room temperature for 1 h followedby a more stringent wash in 0 .1 x SSC/0.1%
SDS at 62 °C for an additional hour. Two probes were used to analyze K rearrangements :
a 500-bp Eco RI-Hpa I constant region cDNA clone and a Hind III 2.8-kb genomic clone
encompassing the entire germline JK region (5) . Probes were labeled to high specific activity
using the random primer method (25) .
Northern Analysis ofTdT Expression.
￿
Poly(A)' mRNA from 38C13 and from EL-4 cells (a
gift from D. Daney, Stanford University) was electrophoresed on a formaldehyde-agarose gel
and transferred to a nitrocellulose filter as described (26) . The filter was baked, prehybri-
dized, hybridized, and washed as described for Southern hybridization . The mouseTdT probe
(27) was a 1.8-kb insert in pUC13 and was a gift from N . Landau, University of California,
School of Medicine, San Francisco, CA .
Cloning and Sequencing Variant V and VK Genes.
￿
cDNA libraries were made from each hy-
bridoma generated from the sIg` tumor variants . Southern blot analysis of rearranged heavy
and x light chain genes showed identical rearrangements in both the parental tumor line and
the representative hybridoma, which insured that fidelity of Ig gene structure was preserved
through the fusion process (19) . cDNA libraries were made using a highly efficient method
described in detail previously (28) . RNA was extracted as previously described (29) and
poly(A)' RNA was selected over an oligo-dT-cellulose column (30) . First strand cDNA was
made using reverse transcriptase (Life Sciences, St . Petersburg, FL) and primers specific for
the i< heavy chain (5'-CAGGAGACGAGGGGGAA-3') and x light chain (5'-TGGATGGTG-
GGAAGATG-3') constant regions just 3' to the variable region . Second strand was synthe-
sized with DNA polymerase I (New England Biolabs) and RNase H (Bethesda Research
Laboratories, Gaithersburg, MD) (31) . The resulting double-stranded cDNA was polished
withT4 DNA polymerase (New England Biolabs) and ligated directly into a Sma I-digested
(New England Biolabs), CIAP (Boehringer Mannheim Biochemicals, Indianapolis, IN)-treated
(32), m13mp19 sequencing vector (33) .JM101 bacteria were made competent by the Hanahan
method and were transformed with the recombinant m13 (34) . The resulting plaques were
lifted onto nitrocellulose filters twice and filters were baked for 2 h at 80'0 under vacuum .
Filters were prehybridized, hybridized, and washed as described above for Southern hybrid-
ization . Filters were dried and exposed to XAR film (Eastman Kodak Co., Rochester, NY)
for 1-6 h . Positive clones were identified and single-stranded sequencing templates weremade
by standard techniques (33) . Clones were sequenced by the dideoxy method (35) . If the iso-
lated clones were in one orientation only, m13 replicative form was isolated and the insert
was cloned in the opposite orientation (using flanking restriction sites Eco RI, Barn HI) into
m13mpl8 .
V region-specific probes for plaque screening were obtained as follows . The 38013 P heavy
chain gene had previously been isolated from a Xgtll total cDNA tumor library (36) . An
Eco RI/Sma I fragment encompassing the entire V region and a portion ofCHI was used
to screen and isolate tt clones from each variant cDNA library. A 550 by Hpa I/Eco RI VK
region (37) was used as a probe for the isolation of K clones from the variant tumor libraries .
Tumor aK
mAb
SIC5' S5A8"
38C 13 + + +
V1 + - -
V2
V3 + - +
V4 + + -1610
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Results
Tumor Variants Display Heterogeneous VK Rearrangements and Identical Reciprocal Product.
We previously reported on Southern blot analysis of the rearranged VK alleles in
these tumorvariants usingaconstant region probe (Fig . 1 A) (19) . Each tumorshares
an identical pattern of rearrangement with its respective hybridoma and demon-
strates that Ig gene structure was preservedthrough the fusion process. In addition,
each hybrid retains 7.2-kb and 5.2-kb rearrangements inherited from the myeloma
fusion partner 8.653 . Uncloned 38C13 lymphoma showed amajor 8.9-kbband along
with three other less prominent rearrangements (8.2, 3 .7, and 3 .4 kb). Each variant
displayed two rearrangements, some ofwhichwere also identified in the38C13 tumor .
Thepattern of rearrangement differed among the tumorvariants, although in some
cases they appeared to share a single rearrangement . The same filter was washed
and reprobed with a genomic fragment containing theJK region (Fig . 1 B) . Each
of the bands detected with theCK probe in the tumorDNA also hybridized to the
JK probe with the exception of the lower faint rearrangement (3.4 kb) in the 38013
tumor. Therefore, these bands represent V/J rearrangements linked to the x con-
stant region segment . In addition, a larger N15-kb band was seen with theJK probe
in 38013 and in each tumor variant . This band did not hybridize to the constant
region probe and indicates that a portion of theJK sequence was retained in the
genome and was displaced from its normal association withCK. The constancy of
this reciprocal gene product provides an independent confirmation of the clonal origin
of these tumorvariants . The 5.2-kbband that originated from the 8.653 fusion partner
did not hybridize with the JK probe .
All Tumor Variants Contain Identical Heavy Chain V Region.
￿
Full-length V clones
were isolated from the V1 and theV4 variant tumorcDNA libraries. A partial se-
quence from theV3 variant tumor was also determined . All of these sequences are
identical (Fig . 2) . Furthercomparison of thoseV regions with the published 38013
sequence (36) demonstrated some minor differences . Therefore, theoriginal 38C13
p V region clone was resequenced in both orientations . It was identical to the vari-
ants describedhere andthepreviously reported 38C13 heavy chain sequence is now
displayed in its corrected form (Fig . 2). This V gene, used by the 38C13 tumor
and its variants, is mosthomologous to the previously reported germlineVB6.5 gene
oftheT15 family derivedfrom a mouseofthe B10Y strain (38) . Thetwo genes differ
from each other in three positions . Thesedifferences might be explained by a germ-
line difference between the C3H and theMY mice or by somatic mutations of
the expressed 38C13V gene. However, since the parentalV sequence and those
ofall thevariants, whichhave been separated by years in culture, areidentical, there
is no evidence of somatic mutation in the tumor .
Thus, the original 38C13 tumor and the three sIg+ variants are all clonally
related. They use the same heavy chain V gene and have identical V/D and D/J
joints . In addition, theVDJ sequences are all identical and, therefore, there is no
evidence for somatic mutation of the heavy chain in this tumor. The differences in
anti-Idbinding in thesevariants (and thus the emergence ofantibody resistanttumor
subclones) are not explained by differences in the heavy chain . These findings cor-
roborate the protein and Ig gene rearrangement analysis that we reported previ-
ously (19) .
All Tumor Variants Use a K Light Chain Gene Differentfrom the Original 38C13.
￿
Full-V3
FIGURE 1 .
￿
Southern blot analysis ofLchain gene rearrangements . DNA was isolated from the
3803 tumor, variant tumors (T) and respective hybridomas (H). The DNA was digested with
Bam HI and probed with CK (A) andJK (B) .
38C TTC ACC
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50
￿
60
W L A L I R N K A N G Y T T E Y S A S V K G R
38C TGG TTG GCT TTG ATT AGA AAC AAA GCT AAT GGT TAC ACA ACA GAG TAC AGT GCA TCT GTG AAG GGT CGG
70
￿
80
F T I S R D N S Q S I L Y L Q M N A L R A E D
ATC TCC AGA GAT AAT TCC CAA AGC ATC CTC TAT CTT CAA ATG AAT GCC CTG AGA GCT GAG GAC
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
FIGURE 2 .
￿
Nucleotide sequences ofVDNA. The amino acid translation is given above the
nucleotide sequences and numbered according to Kabat et al . (42). The complementarity-
determining regions CDR1 andCDR2 and the D andJ segments are indicated . X, ambiguous
bases .
M K L W L N W I F L V T L L N G I Q C
38C GG CTG AAC TGG ATT TTC CTT GTA ACA CTT TTA AAT GGT ATC CAG TGT
V4
V3
V1
1 10 20
E V K L V E S G G G L V Q P G G S L S L S C A
38C GAG GTG AAG CTG GTG GAG TCT GGA GGA GGC TTG GTA CAG CCT GGG GGT TCT CTG AGT CTC TCC TGT GCA
V4 --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
V3
V1
CDR1 _
30 40
A S G F T F T D Y Y M S W V R Q P P G K A L E
38C GCT TCT GGA TTC ACC TTC ACT GAT TAC TAC ATG AGC TGG GTC CGC CAG CCT CCA GGG AAG GCA CTT GAG
V4 --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
V3
V1
CDR2
90 100
--- ---
--- ---
D / J2
---
---
---
---
---
---
S A T Y Y C A R D P N Y Y D G S Y E G Y F D Y
38C AGT GCC ACT TAT TAC TGT GCA AGA GAT CCC AAT TAC TAC GAT GGT AGC TAC GAA GGG TAC TTT GAC TAC
V4 --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
V1 --- ---
110
W A Q G T T L T V S S
38C TGG GCG CAA GGC ACC ACT CTC ACA GTC TCC TCA1612
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length xV region clones were isolated from all sIg+ tumor variants . The nucleic
acid sequences are shown in Fig. 3 and the translated amino acid sequence is dis-
played in Fig. 4. All the vK genes expressed by the variants were similar to one an-
other and appear to be representatives of the highly complexVK-Oxl family (39).
In fact, the sequence ofV1 differs by only a single nucleotide from the previously
reported BALB/C germline gene, R2 (39). Moreover the two x light chain genes
from tumor variants V3 and V4 were identical to each other in their V segments
and their leader sequences . ThisV region gene differed by only five nucleotidesfrom
the previously reported NQ10.4.61 antiphenyloxazolone-producinghybridoma, de-
V3
V4
NQ10
V1
R2
38C
V3
V4
NQ10
V1 __- ___ ___ ___ -__ _-_ G__
￿
_G_
R2 __- ___ ___ ___ ___ _-_ G__
￿
_G_
38C
V3
V4
NQ10
V1
R2
38C
V3
V4
NQ10
V1
R2
38C
V3
V4
V1
TTG CTG CTA ATC AGT GTC ACA GTC ATA GTG TCT AAT GGA
--- --- --- --- ---
---
--- --- --- --- -- ---
￿
-
38C C-- GG- --C T-G TTG T-- TGG C-T CAT -GT G-- C-G T-T
1
￿
10
￿
20
GAA ATT GTG CTC ACC CAG TCT CCA ACC ACC ATG GCT GCA TCT CCC GGG GAG AAG ATC ACT ATC ACC
--- --- --- --- --- --- --- --- --- --- ---
--- --- --- --- ---
---
--- --- --- ---
---
T_C ___ -__ ___ ___ ___ G_A _T_ __A ___ ___ ___ __T ___ ___ ___ G__
--- ___ T__ ___ -__ ___ ___ __- G_A _T_ __A -__ ___ ___ __T ___ ___ ___ G--
--C --C CA- A-G --A --- --- --- T-- T-A C-- T-- --- --- -TG --A -GC --A G--
CDRS
30
￿
40
TGC AGT GCC AGC TCA AGT ATA AGT TCC AAT TAC TTG CAT TGG TAT CAG CAG AAG CCA GGA TTC TCC --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
- - ---
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
--- -AG --A --- CA-
￿
GAC -T- AA- --G --T A-A GC- --- --C --A --C --- --T --- AAA GGT
CDR2
50
￿
60
CCT AAA CTC TTG ATT TAT AGG ACA TCC AAT CTG GCT TCT GGA GTC CCA GCT CGC TTC AGT GGC AGT
--- --- --- --- --- --- --- ---
--- --- --- --- --- --- --- ---
--- --- --- --- --- ---
--- -GG --G C-C --A C-- TAC --- --T -CA A-A -AG C-A --C A-- --- T-A A-G
70
￿
80
GGG TCT GGG ACC TCT TAC TCT CTC ACA ATT GGC ACC ATG GAG GCT GAA GAT GTT GCC ACT TAC TAC
--- --- --- --- --- --- --- --- --- --- --- --- ---
--- ---
--- --- --- --- --- ---
---
-GA GA- --T --C T-- -GC --C A-- -A- C-- --- C-- --- --- A-- --A --- --T --T
CDRS
￿
/ .7
90
￿
100
V3 TGC CAG CAG GGT AGT AGT ATA CCA CGG GGG GTC ACG TTC GGC TCG GGG ACA AAG TTG GAA ATA AAA
￿
1 J4
V4 ___ ___ ___ ___ _-_ __- ___ ___ __
￿
_ _-_ __- ___ ___ ___ -__ ___ ___ __- ___ ___
￿
) J4
NQ10 ___ ___ ___ ___ _-_ ___ ___ __G
V1 --T --- --A A-G --- --- TAC
R2 --T --- --A A-G --- --- TAC
38C --T -TA --- TA- GA- -A- C-G
￿
TA- --- --- --A GG- --- --C --- C-- --- --- ---
￿
) J2
FIGURE 3.
￿
Nucleotide sequencesofVKDNA. The nucleotides are grouped in codons and num-
bered according to Kabat et al . (42) . The CDRS are indicated, as well as theJ regions used by
the 38C13tumor (38C)and its variants . R2 andNQ10 (NQ10.4.61) are previously reported germline
andmRNA sequences, respectively (39), and are both members of the VK-Oxl family .
} J4O
M r ^U
> > > l0
O
N
O
CARROLL ET AL.
￿
1613
L)UQU
F F F F
F F F F
Y Y Y Y
W W W/O
0000
asa
F F
J
mmmm
<< «
« <Im
F FI< m
adad
m070)9)
0000
Ol
h
J J
J J ~ J
Y Y Y ¢
d d C d
co mm0
￿
O
0
IL U.mX
J
FFm2
oCD Z0
F F Hm
O
0000 ,4W
W W W W
a
> > > >
3333
J JtL
mmmm Y Y Y Y
2 Z i < e
J J ~ - O W W W WI
J J J J
2 Zltm Y Y Y Y Y U
M
m Z F F F F mtII
111
I
O
(a m - ooov E
>0 O mmm M
co mm ooov U
I
M
mmm10 W W W W
mmmm ~FFFF
> W Y
m 40 to Y O 0 C m S
ddal
J
>
4
L~I i~fl Y J
O
mmmd maowZ
Y
< < < W co mm0
J J J - o0¢Y
c.,
Z Z Z F O 0000 0
O C
mmmm 0 0 0 J 0
.tC
F F U U U U w
¢ ¢Iv
Y »IS Y>YYI
F F F F
FFFF
J J J~
> O
10000
Id b d d
YYYY
W W W/D 0
00
0
0
0 0
MV ~a Wr-U
»>ef »»1614
￿
ALTERNATIVE Vc GENE REARRANGEMENTS
rived from another member of the V,-Oxl gene family (39) . By comparison, the
parental 38013 tumor expressed a completely different V,c gene, a member of the
V,c9 family (40) . All of the variants used J, c4. By comparison, the parental 38013
tumor use JK2 .
Close inspection of the third hypervariable region reveals considerable variation
in length among variants and 38013 . This is highly unusual since x CDR3s tend
to be constant in length (41), in contrast to the variation in length of the CDR3
region of Ig heavy chains (42). Fig. 3 illustrates the contribution ofV region and
J,c segments to CDR3 . In V3 andV4 there are additional GC nucleotides present
at theV/J boundary. Such nucleotides are highly unusual for x light chains and have
only rarely been reported previously (41, 43, 44) . Since tumors V3 andV4 share
identical heavy chain sequences and V,c regions, and both rearrange to J4, the vari-
able addition ofthese extra nucleotides at the exactV/J recombination site is responsible
for their different pattern of anti-Id binding .
38013 Expresses Terminal Transferase .
￿
Poly(A)+ mRNA from 38013 cells and from
EL-4 cells, which areknown to express TdT, were electrophoresedon a formaldehyde-
agarose gel and transferred to a nitrocellulose filter. The filter was probed with the
mouseTdT probe (Fig . 5) . Lanes 1 and 2 contain 0.5 gg and 1 wg ofEL-4mRNA .
Lane 3 contains 8.5 gg of 38013 mRNA . It is evident that 38013 cells expressTdT
mRNA, albeit in -1/10 of the level expressed in the EL-4 cells .
Discussion
In a previous report we described the isolation of variant tumor cells from the
38013 B cell lymphoma after immunoselection with antiidiotype antibodies (19) .
These variant tumor cells were oftwo major types, those that had completely lost
expression of Ig and those that continued the expression of Ig with an altered struc-
ture . Analysis of the Igs produced by these latter variants suggested that the g heavy
chains were similar to the wild-type tumor but that the x chains were different in
apparent molecular weight . Analysis of the Ig gene rearrangements in these cells
suggested that theheavy chain genes expressed in these cells were identical but that
the light chain genes were different .Anumber ofpossible explanations were consid-
ered for these differences in light chain structure. Among these were the possibility
FIGURE 5 .
￿
Northern blot analysis of TdT expression . mRNA from EL-4
and38013 cells were electrophoresed on a formaldehyde-agarose geland trans-
ferred to nitrocellulose filter. The filter wasprobed with amouseTdTprobe
(27) . (Lanes 1 and 2) 0.5 ug and 1.0 ug of EL-4 mRNA, (lane 3) 8.5 ug of
38013 mRNA . Markers indicate migration of 28S and 18S RNA .CARROLL ET AL .
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ofsomatic point mutation, andcontinuing or alternative rearrangements at thelight
chain locus .
In thepresent report, we directly analyzed themolecularbasis of the Ig heteroge-
neity in these tumor variants . cDNA was cloned for both the heavy chain and light
chain genes from each ofthe variant tumor cells andthe original wild-type cell popu-
lation . Comparison of the heavy chain sequences showed that they were identical
in all of these cells. This result establishes that the 38C13 tumor cell population is
not undergoingV gene somatic mutation . In addition, the results indicate that the
Bcell that gave rise to thetumorhadnotmutated its heavychain gene to any significant
extent because it differed by only three nucleotides from a known germlineVH gene
VB6.5 (38) . Similar arguments can be made from the lack of somatic mutation in
the light chain genes . The identity of the V sequences confirmed the previous sug-
gestions from protein and Southern blot analysis that these tumor cells were all de-
rivedfrom asingle original cell, that is that they are clonally related . Furtherconfirma-
tion of the clonality of the cell populations comes from analysis of light chain gene
rearrangements using theJK region probe (Fig. 1 B) . In addition to the bands that
comigrated with those detected by the C,c probe there was an additional band, de-
tected with theJK probe, which wascommon to all of the variant tumor cells and
to theparental cell . Rearranged fragments ofDNA containingJ sequencesare known
to be produced during the process ofV/Jjoining when theV region used is in in-
verted orientation with respect to the J and constant region segments (45) . Such
reciprocal products of V/J joining can be retained in their original form (46) .
From these data it appears that a plausable order of events in the cell that gave
rise to this tumor were the rearrangement ofa unique heavy chain V region gene
followed by V,c rearrangement on both alleles ; either one ofwhich could have given
rise to aJK reciprocal product . The absence of a common C,c band in tumor vari-
ants would then imply that subsequent rearrangements occurred at both x alleles
in progeny cells . Ongoing light chain rearrangements have been described previ-
ously in anAbelsonleukemia virus-transformedBcell line. Lewiset al . (47) showed
by Southern blot analysis that a rearranged x allele can undergo further recombi-
nation . Recently an Ablesonleukemia virus pre-B cell line has been described that
is capable ofproceeding toX recombination (48). Future studies on the 38C13 tumor
should be able to test the possibility that the recombinase system (49) may still be
active in these cells and that ongoing K light chain recombination may be occur-
ring . Ifthis were the case variant tumor cells should give rise to subsequent variants
in culture . If so, it will be extremely interesting to determine whether the repetitive
use of theV,c-Oxl gene family observed in the current set of data continues to occur.
Examination of the sequences of the productive V, genes revealed some extremely
interesting phenomena. We noticed that theV region sequence of the variant V3
and the variant V4 were identical to each other and that each of these tumors had
rearranged this identicalV region gene to the same J4 segment . Theonly difference
between these genes is in the length of theirCDR3 region . Each ofthem has addi-
tional nucleotides composed mostly of Cs and Gs in thejoint between theV and
J segments. V3 has an unusually long CDR3 length composed of 11 amino acids .
Although the addition of extra nucleotides at the V/D/J joint is commonly seen in
heavychaingene rearrangement, it hasonly rarely been observed in lightchaingenes .
In general V/J recombination takes place between codon 95 of the V,c segment and1616
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the first codon, 96, of the germline JK segment . The exact splice junction may be
located in either codon, but compensation occurs so that a CDR-3 length of nine
amino acids results . However, additional nucleotides maybe present 3' to thegerm-
line VK segment and 5' to germline JK located just adjacent to the respective con-
served heptamer recombination sequence . In murine VK light chains one to two
such nucleotides may be present and areusually Cs, sometimesAs (44) . These nucleo-
tides have been shown to participate in V/Jjoining occasionally. Interestingly, Kaart-
tinen and Makela (41) have observed that a substantial portion of the murine VKO.
response consists of light chains with extra long CDR-3 segments composed of 11
amino acids, similar to V3 reported here (41) . They noted the presence of up to
five extra nucleotides (mostly C) at the V,JK joint and postulate that these are con-
tributed by an unusually long string of germline nucleotides 3' toVK before the hep-
tamer. Up to seven nucleotideswould have to be postulated to contribute to theextra
segments observed in V3, and here they are mostly Gs instead of the more com-
monly observedCs . Alternatively, theaddition of extra nucleotides, so calledN regions,
in heavychains is thought to be mediated by the action ofthe enzyme terminal deoxy-
nucleotide transferase (TdT) (27) . This enzyme has a preference for Gs and Cs and
is thought to be inactivated by the time B cells begin to rearrange their light chain
genes . Recently Heller et al . (43) described nucleotides not encoded by germline
V genes orJ regions at the site ofV,/J, recombination in antigalactan antibodies .
In addition, Klobeck et al . (44) also found a GC-rich region at the VK/JK joint in
an aberrant rearrangement involved in a(2:8) translocation inaBurkitt'slymphoma
cell line . Our finding of the message forTdT in the 38C13 tumor cells provides an
explanation for the addition ofN sequences at the VKjoints in these cells and vio-
lates the notion that TdT is absent from cells of the fully differentiated B cell stage .
Since the V,/J, joints in variant V3 and variant V4 are different, these genes
must have been created by independentjoining events in the different subclones of
this tumor, even though the same V gene was used . Interestingly, theV gene used
by these two variant tumor cells is virtually identical to a gene used by a hybridoma
with a binding activity for phenyloxazolone and is a member of the V,-Oxl gene
family (39) . Inspection ofthenucleic acid sequence ofvariant V1 shows that adifferent
VK gene has been used by this variant, but that it is virtually identical to another
previously reported member of the V,-Oxl gene family R2 (39) . All of these genes
of variants V1, V3, V4, and the two previously reported members of the V,-Oxl
family are completely differentfrom the gene used by theoriginal 38C13 tumor cell,
which is amember of adifferentV gene family. Therefore, it appearsthat thistumor
has chosen alternative rearrangements at the VK light chain locus to create a
number of different subclone variants of the prototype tumor cell, and that all of
these variants have been created by the use of genes from the sameV region family.
It is possible that the repetitive use of the same gene family for rearrangements is
based on the proximity of the V,-Oxl gene family to the J region . Subsequent
studies on the organization of theVK locus as well as that of the locus in the 38C13
tumor cell should be able to provide a test of this proximity hypothesis.
These studies on the sequence of the expressedVK genes in variants of the 38C13
tumor have provided an explanation for the idiotypic heterogeneity of the tumor
population . As previously suspected from studies on the isolated light chain pro-
teins andon Southern blot analysis ofthe light chain genes, thetumor heterogeneityCARROLL ET AL.
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at the Id level is completely accounted for by variations in the amino acid sequence
of the light chains. This variation can be extremely subtle. For instance, the entire
difference between variant V3 and V4 is accounted for by three amino acids at the
V/J joint of the light chain. Yet these two variants are easily distinguishable by a
panel of syngeneic antiidiotype mAbs. It is clear from these studies that at some
time in the history of this tumor alternative light chain gene rearrangements rather
than somatic point mutation occurred and created Id diversity within the tumor
cell population.
Summary
Idiotype variants of 38C13, a murine B cell lymphoma, have been isolated by im-
munoselection with antiidiotype mAbs. The V region genes for the x light chains
and It heavy chains expressed by these tumor cells were sequenced and compared.
There was no evidence for V region somatic point mutation in this tumor. However,
while the heavy chain genes were all identical, the light chain genes were all different.
The light chain genes of each variant were derived from the VK-Oxl gene family
and joined to J,K4, whereas the light chain gene of the parental tumor was derived
from the VK9 family and joined to JK2. Two of the variants used the identical V,
gene but differed by the inclusion of a variable number of additional nucleotides
in the V/J joint. Thus, the idiotypic heterogeneity of this B cell lymphoma arises
as a consequence of alternative light chain rearrangements rather than point muta-
tion. This process repetitively uses members of the same VK gene family. Two of
the variants use the identical Vi, and JK gene segments but differ by the presence
of extra nucleotides at the V,/J, joint.
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